Aimee Culverhouse

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Kappa-opioid receptor (KOPr) agonists have pre-clinical anti-cocaine and analgesic effects. However, side effects including sedation, dysphoria, aversion, anxiety and depression limit their therapeutic development. The unique structure of salvinorin A has been used to develop longer acting KOPr agonists. We evaluate two novel C-2 analogues of salvinorin A,(More)
  • 1